- Home
- Equipment
- usa california
- live vaccine
Refine by
Live Vaccine Equipment Supplied In Usa California
9 equipment items found
Manufactured by:Hygieia Biological Laboratories based inWoodland, CALIFORNIA (USA)
Avian Encephalomyelitis-Fowl Pox Vaccine is a chicken embryo propagated, freeze-dried, live virus vaccine for wing web administration in chickens. The vaccine contains both AE and fowl pox virus fractions in a single ...
Manufactured by:Hygieia Biological Laboratories based inWoodland, CALIFORNIA (USA)
Avian Encephalomyelitis Vaccine is a chicken embryo propagated, freeze-dried, live virus vaccine for wing web administration in ...
Manufactured by:Hygieia Biological Laboratories based inWoodland, CALIFORNIA (USA)
Pigeon Pox Vaccine is a chicken embryo propagated, frcczc-dricd, live virus vaccine for wing web administration in ...
Manufactured by:Ibio, Inc. based inBryan, TEXAS (USA)
Antibody discovery is challenging. Only 5 of every 5000 concepts make it into the clinic.1 Many antibody failures can be attributed to a lack of specificity for disease-causing cells versus healthy cells and a lack of efficacy – both potentially due to binding the wrong epitope. ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Meissa is developing MV-012-968, an intranasal (needle-free), adjuvant-free, live attenuated vaccine candidate, to protect infants and at-risk, older adults from RSV. In Phase 1 clinical trials, Meissa’s RSV vaccine candidate was well-tolerated, heavily attenuated, and stimulated a strong RSV-specific mucosal IgA response in participants ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and immunity following SARS-CoV-2 infection wanes, so vaccine technologies that enhance immunogenicity are required. ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Meissa is developing a live attenuated COVID-19 vaccine candidate, MV-014-212, to induce mucosal and systemic immunity and protect against SARS-CoV-2, the novel coronavirus that causes COVID-19. Like Meissa’s RSV vaccine candidate, MV-014-212 offers significant potential advantages for global deployment, including needle-free intranasal ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Respiratory viruses are one of the biggest threats to human health. Vaccines are the most effective healthcare tool to combat infectious diseases and have saved more lives than any other type of medicine. Meissa is dedicated to creating safe, potent, stable, and accessible intranasal live attenuated vaccines that can prevent ...
Manufactured by:Hygieia Biological Laboratories based inWoodland, CALIFORNIA (USA)
Hygieias hemorrhagic enteritis live virus vaccine is a lyophilizcd preparation made using a cell culture propagated avirulent strain of type 2 avian adenovirus of pheasant origin. The vaccine has been formulated to provide maximum protection with minimal or no post-vaccination side effects. It is recommended for drinking water ...